Login / Signup

Phase II Trial of Afatinib in Patients With EGFR -Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A.

Scott N GettingerZihe SongKaren L ReckampJeffrey A MoscowRobert C GrayVictoria WangLisa Meier McShaneLawrence V RubinsteinDavid R PattonP Mickey WilliamsStanley R HamiltonXiao-Tang KongJames V TricoliBarbara A ConleyCarlos L ArteagaLyndsay N HarrisPeter J O'DwyerAlice P ChenKeith T Flaherty
Published in: JCO precision oncology (2024)
exon 18 fusions may be of interest.
Keyphrases
  • epidermal growth factor receptor
  • small cell lung cancer
  • phase iii
  • open label
  • tyrosine kinase
  • study protocol
  • phase ii
  • advanced non small cell lung cancer
  • clinical trial
  • placebo controlled
  • wild type